Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Merck & Co., Inc. Director's Dealing 2018

May 8, 2018

284_dirs_2018-05-08_9690913e-3db0-43cc-b50b-5c34bb4cecc7.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Merck & Co., Inc. (MRK)
CIK: 0000310158
Period of Report: 2018-05-04

Reporting Person: Karachun Rita A (Sr. VP Fince-Global Controller)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2018-05-04 Restricted Stock Unit $ A 3636.0000 Acquired 2021-05-04 Common Stock (3636.0000) Direct
2018-05-04 Stock Option (right to buy) $57.7500 A 25617.0000 Acquired 2028-05-03 Common Stock (25617.0000) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 21174.9720 Direct

Footnotes

F1: Holdings include shares acquired in dividend reinvestment transactions.

F2: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock.

F3: These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 5/4/2019, 5/4/2020 and 5/4/2021.

F4: The option vests and becomes exercisable in three equal installments on 5/4/2019, 5/4/2020 and 5/4/2021.